Bellerophon Therapeutics Cash from Financing (TTM) Analysis

Bellerophon Therapeutics Inc (BLPH)

0.055 0.00 (0.00%) USD | OTCM | Apr 25, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
September 30, 2023	4.968M
June 30, 2023	4.968M
March 31, 2023	4.942M
December 31, 2022	-0.04M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020	57.57M
September 30, 2020	57.51M
June 30, 2020	57.93M
March 31, 2020	2.85M
December 31, 2019	6.167M
September 30, 2019	6.236M
June 30, 2019	6.261M

Date	Value
March 31, 2019	6.568M
December 31, 2018	0.166M
September 30, 2018	1.271M
June 30, 2018	24.91M
March 31, 2018	27.47M
December 31, 2017	27.78M
September 30, 2017	37.97M
June 30, 2017	15.57M
March 31, 2017	13.49M
December 31, 2016	13.21M
September 30, 2016	2.055M
June 30, 2016	0.786M
March 31, 2016	-0.897M
December 31, 2015	54.01M
September 30, 2015	52.48M
June 30, 2015	53.17M
March 31, 2015	53.04M
December 31, 2014	87.38M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.04M

Minimum

Dec 2022

57.93M

Maximum

Jun 2020

19.03M

Average

6.167M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks